BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 27622024)

  • 1. Investigating potential exogenous tumor initiating and promoting factors for Cutaneous T-Cell Lymphomas (CTCL), a rare skin malignancy.
    Litvinov IV; Shtreis A; Kobayashi K; Glassman S; Tsang M; Woetmann A; Sasseville D; Ødum N; Duvic M
    Oncoimmunology; 2016 Jul; 5(7):e1175799. PubMed ID: 27622024
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification of geographic clustering and regions spared by cutaneous T-cell lymphoma in Texas using 2 distinct cancer registries.
    Litvinov IV; Tetzlaff MT; Rahme E; Habel Y; Risser DR; Gangar P; Jennings MA; Pehr K; Prieto VG; Sasseville D; Duvic M
    Cancer; 2015 Jun; 121(12):1993-2003. PubMed ID: 25728286
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comprehensive analysis of cutaneous T-cell lymphoma (CTCL) incidence and mortality in Canada reveals changing trends and geographic clustering for this malignancy.
    Ghazawi FM; Netchiporouk E; Rahme E; Tsang M; Moreau L; Glassman S; Provost N; Gilbert M; Jean SE; Pehr K; Sasseville D; Litvinov IV
    Cancer; 2017 Sep; 123(18):3550-3567. PubMed ID: 28493286
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Primary cutaneous T-cell lymphoma (mycosis fungoides and Sézary syndrome): part I. Diagnosis: clinical and histopathologic features and new molecular and biologic markers.
    Jawed SI; Myskowski PL; Horwitz S; Moskowitz A; Querfeld C
    J Am Acad Dermatol; 2014 Feb; 70(2):205.e1-16; quiz 221-2. PubMed ID: 24438969
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cutaneous T cell lymphomas: mycosis fungoides, Sezary syndrome and HTLV-I-associated adult T cell leukemia (ATL) in Mali, West Africa: a clinical, pathological and immunovirological study of 14 cases and a review of the African ATL cases.
    Fouchard N; Mahe A; Huerre M; Fraitag S; Valensi F; Macintyre E; Sanou F; de The G; Gessain A
    Leukemia; 1998 Apr; 12(4):578-85. PubMed ID: 9557617
    [TBL] [Abstract][Full Text] [Related]  

  • 6. New perspectives in experimental and clinical research for cutaneous T cell lymphomas.
    Burg G; Häffner A; Böni R; Dommann S; Dummer R
    Recent Results Cancer Res; 1995; 139():225-37. PubMed ID: 7597294
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Skin Microbiome in Cutaneous T-Cell Lymphomas (CTCL)-A Narrative Review.
    Łyko M; Jankowska-Konsur A
    Pathogens; 2022 Aug; 11(8):. PubMed ID: 36015055
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cutaneous manifestations of Epstein-Barr virus-associated T-cell lymphoma.
    Su IJ; Tsai TF; Cheng AL; Chen CC
    J Am Acad Dermatol; 1993 Nov; 29(5 Pt 1):685-92. PubMed ID: 8227539
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Primary cutaneous T-cell lymphoma (mycosis fungoides and Sézary syndrome): part II. Prognosis, management, and future directions.
    Jawed SI; Myskowski PL; Horwitz S; Moskowitz A; Querfeld C
    J Am Acad Dermatol; 2014 Feb; 70(2):223.e1-17; quiz 240-2. PubMed ID: 24438970
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The relevance of peripheral blood T-helper 1 and 2 cytokine pattern in the evaluation of patients with mycosis fungoides and Sézary syndrome.
    Papadavid E; Economidou J; Psarra A; Kapsimali V; Mantzana V; Antoniou C; Limas K; Stratigos A; Stavrianeas N; Avgerinou G; Katsambas A
    Br J Dermatol; 2003 Apr; 148(4):709-18. PubMed ID: 12752128
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Measurement of Quality of Life in Patients with Mycosis Fungoides/Sézary Syndrome Cutaneous T-Cell Lymphoma: Development of an Electronic Instrument.
    McCaffrey S; Black RA; Nagao M; Sepassi M; Sharma G; Thornton S; Kim YH; Braverman J
    J Med Internet Res; 2019 Jan; 21(1):e11302. PubMed ID: 30617041
    [TBL] [Abstract][Full Text] [Related]  

  • 12. STAT5 induces miR-21 expression in cutaneous T cell lymphoma.
    Lindahl LM; Fredholm S; Joseph C; Nielsen BS; Jønson L; Willerslev-Olsen A; Gluud M; Blümel E; Petersen DL; Sibbesen N; Hu T; Nastasi C; Krejsgaard T; Jæhger D; Persson JL; Mongan N; Wasik MA; Litvinov IV; Sasseville D; Koralov SB; Bonefeld CM; Geisler C; Woetmann A; Ralfkiaer E; Iversen L; Odum N
    Oncotarget; 2016 Jul; 7(29):45730-45744. PubMed ID: 27329723
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Full clinical recovery after topical acyclovir treatment of Epstein-Barr virus associated cutaneous B-cell lymphoma in patient with mycosis fungoides.
    Copur MS; Deshpande A; Mleczko K; Norvell M; Hrnicek GJ; Woodward S; Frankforter S; Mandolfo N; Fu K; Chan WC
    Croat Med J; 2005 Jun; 46(3):458-62. PubMed ID: 15861527
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Analysis of CTCL cell lines reveals important differences between mycosis fungoides/Sézary syndrome
    Netchiporouk E; Gantchev J; Tsang M; Thibault P; Watters AK; Hughes JM; Ghazawi FM; Woetmann A; Ødum N; Sasseville D; Litvinov IV
    Oncotarget; 2017 Nov; 8(56):95981-95998. PubMed ID: 29221181
    [No Abstract]   [Full Text] [Related]  

  • 15. Epidemiology of Cutaneous T-Cell Lymphomas: A Systematic Review and Meta-Analysis of 16,953 Patients.
    Dobos G; Pohrt A; Ram-Wolff C; Lebbé C; Bouaziz JD; Battistella M; Bagot M; de Masson A
    Cancers (Basel); 2020 Oct; 12(10):. PubMed ID: 33050643
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Presence of Epstein-Barr virus in cutaneous lesions of mycosis fungoides and Sézary syndrome.
    Dreno B; Celerier P; Fleischmann M; Bureau B; Litoux P
    Acta Derm Venereol; 1994 Sep; 74(5):355-7. PubMed ID: 7817670
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Demographic patterns of cutaneous T-cell lymphoma incidence in Texas based on two different cancer registries.
    Litvinov IV; Tetzlaff MT; Rahme E; Jennings MA; Risser DR; Gangar P; Netchiporouk E; Moreau L; Prieto VG; Sasseville D; Duvic M
    Cancer Med; 2015 Sep; 4(9):1440-7. PubMed ID: 26136403
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cutaneous T cell lymphoma: the helping hand of dendritic cells.
    Edelson RL
    Ann N Y Acad Sci; 2001 Sep; 941():1-11. PubMed ID: 11594563
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Deregulation in STAT signaling is important for cutaneous T-cell lymphoma (CTCL) pathogenesis and cancer progression.
    Netchiporouk E; Litvinov IV; Moreau L; Gilbert M; Sasseville D; Duvic M
    Cell Cycle; 2014; 13(21):3331-5. PubMed ID: 25485578
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An association between newly diagnosed cutaneous T cell lymphoma and prior impetigo: a nested case-control study.
    Boursi B; Haynes K; Mamtani R; Yang YX
    Arch Dermatol Res; 2016 Nov; 308(9):661-664. PubMed ID: 27613059
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.